Pharmaceuticals

SUNFLOWER

SUNFLOWER released FY2026 Q1 earnings on April 26 After-Market (BJT), actual revenue CNY 54.56 M, actual EPS CNY -0.0041

SUNFLOWER released FY2025 Annual Earnings on April 21 After-Market (BJT), actual revenue CNY 271.53 M, actual EPS CNY 0.003

SUNFLOWER released FY2025 Q4 earnings on April 21 After-Market (BJT), actual revenue CNY 72.01 M, actual EPS CNY -0.0044

SUNFLOWER to Release FY2026 Q1 Earnings on April 27 After-Market (BJT)

SUNFLOWER FY2025 Annual Earnings Release on April 22, 2026 After-Market BJT

SUNFLOWER released FY2025 9 Months Earnings on October 27 After-Market BJT, actual revenue CNY 199.52 M, actual EPS CNY 0.0012

SUNFLOWER released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 55.1 M, actual EPS CNY 0

SUNFLOWER FY2025 Q3 Earnings Release on October 28, 2025, After-Market (BJT)

SUNFLOWER released FY2025 Semi-Annual Earnings on August 28 Pre-Market (BJT), actual revenue CNY 144.42 M, actual EPS CNY 0.0009

SUNFLOWER released FY2025 Q2 earnings on August 28 Pre-Market (BJT), actual revenue CNY 72.19 M, actual EPS CNY 0.0012

SUNFLOWER to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

Xiangrikui 2025 Q1 Earnings Report: Revenue Decrease and Net Loss

SUNFLOWER released FY2025 Q1 earnings on April 25 After-Market (BJT), actual revenue CNY 72.23 M, actual EPS CNY -0.0001

SUNFLOWER FY2025 Q1 Earnings Release on April 26 After-Market BJT

SUNFLOWER released FY2024 Annual Earnings on April 17 After-Market (BJT), actual revenue CNY 330.37 M, actual EPS CNY 0.006

SUNFLOWER released FY2024 Q4 earnings on April 17 After-Market (BJT), actual revenue CNY 103.39 M, actual EPS CNY 0.0048

SUNFLOWER to Release FY2024 Annual Earnings on April 18 After-Market BJT

Sunflower Expects a 57%-71% Decline in Net Profit for 2024

Zhejiang Sunflower Great Health Co., Ltd. to Announce Q3 2024 Earnings on October 26, 2024

SUNFLOWER released FY2024 9 Months Earnings on October 25 After-Market (BJT), with actual revenue of 226.98 M CNY and EPS of 0.0026 CNY

600030

06030

300111

The three major A-share indices fell between 0.4% and 1% in the first half of the day, with chip stocks performing weakly. The central parity rate of the RMB against the USD was adjusted to 7.0064, reaching a new high for 2023. The People's Bank of China conducted reverse repurchase operations, with a net injection of 175.3 billion yuan. The performance of domestic bank stocks was mixed, with CITIC Securities showing significant earnings growth. Computing power leasing concept stocks retracted, and SUNFLOWER was placed under investigation for suspected information disclosure violations

AASTOCKS

CITIC Securities Co., Ltd.

CITIC SEC

The three major A-share indices in Shanghai and Shenzhen fell by 0.4% to 1% in the first half of the day, with chip stocks showing weakness and computing power leasing concept stocks giving back gains

According to the Zhitong Finance APP, SUNFLOWER released its Q3 2025 report, stating that the company's operating revenue for the first three quarters was 200 million yuan, a year-on-year decrease of 12.09%. The net profit attributable to shareholders of the listed company was 1.3062 million yuan, a year-on-year decrease of 53.10%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 93,300 yuan. The basic earnings per share were 0.001 yuan

Zhitong

SUNFLOWER released its performance for the first three quarters, with a net profit attributable to the parent company of 1.3062 million yuan, a decrease of 53.10%

301563

On October 16th, a total of 23 stocks appeared on the leaderboard, among which 8 stocks achieved net purchases and 15 stocks experienced net sales. The top three stocks with net purchases were SUNFLOWER (CNY 130 million), iCkey (CNY 95.61 million), and Zhongdian Xinlong (CNY 47.85 million); the top three stocks with net sales were Tianji Shares (CNY 217 million), Hubei Yihua (CNY 153 million), and Beifang Changlong (CNY 138 million)

36Kr

ICkey

Institutions sold Tianji Holdings and 14 other stocks today, buying SUNFLOWER for 130 million yuan

300204

600276

688513

002755

The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%, ASK PHARM falling over 7%, and multiple stocks including Staidson BioPharm, Hengrui Pharma, and EASTON BIOPHARMACEUTICALS declining

Staidson BioPharm

Hengrui Pharma

EASTON BIOPHARMACEUTICALS

ASK PHARM

The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%

300436

300006

688428

09969

The pharmaceutical sector fluctuated and strengthened, with ASK PHARM hitting the limit up, SUNFLOWER rising over 13%, and Cosunter, Xinlitai, Lummy, and INNOCARE among the top gainers

Cosunter

Lummy

InnoCare Pharma

INNOCARE

The pharmaceutical sector fluctuates and strengthens, ASK PHARM hits the limit up

SUNFLOWER hit the daily limit today, with a total transaction volume of 390 million yuan, buying 157 million yuan and selling 233 million yuan, resulting in a net sell of 76.105 million yuan. Institutions had a net sell of 46.5458 million yuan. Dongxing Securities and Guotai Junan Securities bought 35.8086 million yuan and 30.8493 million yuan respectively, while Zheshang Securities and Guojin Securities sold 97.0106 million yuan and 28.3728 million yuan respectively. As of the close on September 23, SUNFLOWER rose 20%, with a turnover rate of 32.42%, a volatility of 19.16%, a 5-day increase of 43.95%, and a 30-day increase of 80.3%

SUNFLOWER today hit the daily limit with a net sell of 46.5458 million yuan by 1 institution

688553

300705

002422

688221

The chemical pharmaceutical sector rose in early trading, with SUNFLOWER hitting the daily limit of a 20cm increase, followed by gains in Froniter Biotechnologies, HUIYU PHARMACEUTICAL, JIUDIAN PHARMACEUTICAL, KELUN PHARMA, and Yuandong Biotech

HUIYU PHARMACEUTICAL

JIUDIAN PHARMACEUTICAL

KELUN PHARMA

Froniter Biotechnologies

The chemical pharmaceutical sector rose in early trading, with SUNFLOWER hitting the daily limit of a 20cm increase

SUNFLOWER plans to acquire 100% equity of Xipu Materials and 40% equity of Beid Pharmaceutical through the issuance of shares and cash payment, and to raise supporting funds. Xipu Materials focuses on the research and development and sales of high-end semiconductor materials, while Beid Pharmaceutical is a holding subsidiary mainly engaged in drug research and manufacturing. This transaction will enhance the company's asset quality, promote long-term development, and enter the high-end semiconductor materials field, adding new profit growth points. The company's stock will resume trading on September 22, 2025

SUNFLOWER plans to acquire 100% equity of Xipu Materials and 40% equity of Beid Pharmaceutical. Stock resumption

603359

Dongzhu Ecological Environment Protection disclosed a restructuring plan, intending to acquire KaiRuiXingTong; ST United's merger and acquisition of RunTian Industrial has made substantial progress; SUNFLOWER plans to conduct a private placement to acquire a controlling stake in XiPu Materials and 40% equity in BeiDe Pharmaceutical... Recently, multiple A-share listed companies have disclosed progress in mergers and acquisitions, showcasing a new trend of actively utilizing mergers and acquisitions tools to enhance quality and strengthen core competitiveness

Wallstreetcn

Dongzhu Ecological Environment Protection

China Securities Journal: Mergers and acquisitions are active, and listed companies have sufficient new quality improvement momentum

SUNFLOWER(300111.SZ)